Novartis

News

Novartis may have found a buyer for Sandoz; report

Just a few weeks after Novartis revealed it was considering a sale of its generics business Sandoz, there are reports that a potential buyer has already come forward.

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

AbbVie's Humira tops ICER's list of unwarranted price hikes ...

With drug pricing controls back on the legislative table in the US, the influential Institute for Clinical and Economic Review (ICER) has published its third report on "unsupported" price i

News

Merck's oral PCSK9 drug matches injectables in early trials

Injectable antibodies targeting PCSK9 have failed to take off as expected in the cholesterol-lowering market, but Merck & Co hopes to do much better with an oral alternative.

News

Swiss socialists say government should buy Sandoz

Switzerland's Social Democratic Party has argued that the government should step in and acquire Novartis' generics unit Sandoz if the company decides to sell it, according to local press re

News

Novartis' iptacopan hits the mark in rare kidney disease C3G

Novartis has chalked up another successful trial for its targeted factor B inhibitor iptacopan, an orally-active drug trying to challenge antibody-based therapies for diseases associated wi

News

Close-up image of a firm handshake between two colleagues

Novartis finally sells Roche stake, for almost $21 billion

After more than 20 years, Novartis has finally decided to sell its substantial share in fellow Swiss pharma group Roche for $20.7 billion, a decent return on its original $5 billion investm

Novartis may have found a buyer for Sandoz; report

AbbVie's Humira tops ICER's list of unwarranted price hikes ...

Merck's oral PCSK9 drug matches injectables in early trials

Swiss socialists say government should buy Sandoz

Novartis' iptacopan hits the mark in rare kidney disease C3G

Novartis finally sells Roche stake, for almost $21 billion

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Novartis

Editor's Picks